BIOMAT Database Logo BIOMAT Database Logo

APRI-M6 for predicting long-term outcome of chronic hepatitis C patients after interferon-based therapy: more questions than answers. 2007

Tung-Hung Su, and Jia-Horng Kao, and Ding-Shinn Chen

UI MeSH Term Description Entries
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D010976 Platelet Count The number of PLATELETS per unit volume in a sample of venous BLOOD. Blood Platelet Count,Blood Platelet Number,Platelet Number,Blood Platelet Counts,Blood Platelet Numbers,Count, Blood Platelet,Count, Platelet,Counts, Blood Platelet,Counts, Platelet,Number, Blood Platelet,Number, Platelet,Numbers, Blood Platelet,Numbers, Platelet,Platelet Count, Blood,Platelet Counts,Platelet Counts, Blood,Platelet Number, Blood,Platelet Numbers,Platelet Numbers, Blood
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D001219 Aspartate Aminotransferases Enzymes of the transferase class that catalyze the conversion of L-aspartate and 2-ketoglutarate to oxaloacetate and L-glutamate. EC 2.6.1.1. Aspartate Aminotransferase,Aspartate Transaminase,Glutamic-Oxaloacetic Transaminase,SGOT,Aspartate Apoaminotransferase,Glutamate-Aspartate Transaminase,L-Aspartate-2-Oxoglutarate Aminotransferase,Serum Glutamic-Oxaloacetic Transaminase,Aminotransferase, Aspartate,Aminotransferase, L-Aspartate-2-Oxoglutarate,Aminotransferases, Aspartate,Apoaminotransferase, Aspartate,Glutamate Aspartate Transaminase,Glutamic Oxaloacetic Transaminase,Glutamic-Oxaloacetic Transaminase, Serum,L Aspartate 2 Oxoglutarate Aminotransferase,Serum Glutamic Oxaloacetic Transaminase,Transaminase, Aspartate,Transaminase, Glutamate-Aspartate,Transaminase, Glutamic-Oxaloacetic,Transaminase, Serum Glutamic-Oxaloacetic
D019698 Hepatitis C, Chronic INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS. Chronic Hepatitis C

Related Publications

Tung-Hung Su, and Jia-Horng Kao, and Ding-Shinn Chen
A simple noninvasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapy.
November 2006, Hepatology (Baltimore, Md.),
Tung-Hung Su, and Jia-Horng Kao, and Ding-Shinn Chen
Maintenance interferon for chronic hepatitis C: more issues than answers?
August 2000, Hepatology (Baltimore, Md.),
Tung-Hung Su, and Jia-Horng Kao, and Ding-Shinn Chen
Long-term outcome after interferon therapy in patients with chronic hepatitis C.
January 2007, Annals of hepatology,
Tung-Hung Su, and Jia-Horng Kao, and Ding-Shinn Chen
Long-term outcome after interferon therapy in elderly patients with chronic hepatitis C.
January 2007, Intervirology,
Tung-Hung Su, and Jia-Horng Kao, and Ding-Shinn Chen
Recurrent hepatitis C in transplanted patients: more questions than answers.
January 2003, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver,
Tung-Hung Su, and Jia-Horng Kao, and Ding-Shinn Chen
Asymptomatic hepatitis C infection. More questions than answers.
May 1994, BMJ (Clinical research ed.),
Tung-Hung Su, and Jia-Horng Kao, and Ding-Shinn Chen
Long-term outcome of chronic hepatitis C after sustained virological response to interferon-based therapy.
May 2013, Alimentary pharmacology & therapeutics,
Tung-Hung Su, and Jia-Horng Kao, and Ding-Shinn Chen
Long-term effects of interferon-based therapy for chronic hepatitis C.
January 2007, Oncology,
Tung-Hung Su, and Jia-Horng Kao, and Ding-Shinn Chen
Fertility Therapy and Long-Term Cardiovascular Risk: Raising More Questions Than Answers?
September 2017, Journal of the American College of Cardiology,
Tung-Hung Su, and Jia-Horng Kao, and Ding-Shinn Chen
Hepatitis C virus and lipid profiles: more questions than answers?
December 2011, Hepatology international,
Copied contents to your clipboard!